A novel universal small-molecule detection platform based on antibody-controlled Cas12a switching
Tieqiang Sun,Wen Wang,Feng Wang,Weili Shen,Lu Geng,Yiyang Zhang,Meng Bi,Tingting Gong,Cong Liu,Changjiang Guo,Zhanxin Yao,Tianhui Wang,Jialei Bai
DOI: https://doi.org/10.1016/j.bios.2023.115897
IF: 12.545
2023-12-06
Biosensors and Bioelectronics
Abstract:Molecular diagnostics play an important role in illness detection, prevention, and treatment, and are vital in point-of-care test. In this investigation, a novel CRISPR/Cas12a based small-molecule detection platform was developed using Antibody-Controlled Cas12a Biosensor (ACCBOR), in which antibody would control the trans-cleavage activity of CRISPR/Cas12a. In this system, small-molecule was labelled around the PAM sites of no target sequence(NTS), and antibody would bind on the labelled molecule to prevent the combination of CRISPR/Cas12a, resulting the decrease of trans-cleavage activity. Biotin-, digoxin-, 25-hydroxyvitamin D3 (25-OH-VD3)-labelled NTS and corresponding binding protein were separately used to verify its preformance, showing great universality. Finally, one-pot detection of 25-OH-VD3 was developed, exhibiting high sensitivity and excellent specificity. The limit of detection could be 259.86 pg/mL in serum within 30 min. This assay platform also has the advantages of low cost, easy operation (one-pot method), and fast detection (∼30 min), would be a new possibilities for the highly sensitive detection of other small-molecule targets.
biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology